Cancer is the disease in which cell grows abnormally and may cause a tumor. In lung cancer, the cells of lungs starts to grow in uncontrolled manner later form a tumor and can be spread into other body parts. Small cell lung cancer and non-small cell lung cancer are the two main types of lung cancer. As per the stats of Lung Cancer Alliance (leading nonprofit organization dedicated to fighting lung cancer), out of overall lung cancer, around 80 to 85% cases found are of non-small cell lung ... Read more
Global non-small cell lung cancer drugs market size is forecast to grow by USD 14.28 billion during 2019-2023 at a CAGR of 13%, with biologics segment having the largest market share. Non-small cell lung cancer drugs market analysis indicates growth will be driven by the strong drug pipeline and drug approvals. Non-small cell lung cancer drugs industry growth will also be impacted by the use of predictive biomarkers for the development of cost-effective therapies.
